Cargando…
Direct oral anticoagulants in antiphospholipid syndrome with venous thromboembolism: Impact of the European Medicines Agency guidance
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6971326/ https://www.ncbi.nlm.nih.gov/pubmed/31989078 http://dx.doi.org/10.1002/rth2.12287 |
| _version_ | 1783489702362349568 |
|---|---|
| author | Fazili, Masarret Stevens, Scott M. Woller, Scott C. |
| author_facet | Fazili, Masarret Stevens, Scott M. Woller, Scott C. |
| author_sort | Fazili, Masarret |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6971326 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-69713262020-01-27 Direct oral anticoagulants in antiphospholipid syndrome with venous thromboembolism: Impact of the European Medicines Agency guidance Fazili, Masarret Stevens, Scott M. Woller, Scott C. Res Pract Thromb Haemost Commentaries John Wiley and Sons Inc. 2019-12-12 /pmc/articles/PMC6971326/ /pubmed/31989078 http://dx.doi.org/10.1002/rth2.12287 Text en © 2019 The Authors. Research and Practice in Thrombosis and Haemostasis published by Wiley Periodicals, Inc on behalf of International Society on Thrombosis and Haemostasis. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Commentaries Fazili, Masarret Stevens, Scott M. Woller, Scott C. Direct oral anticoagulants in antiphospholipid syndrome with venous thromboembolism: Impact of the European Medicines Agency guidance |
| title | Direct oral anticoagulants in antiphospholipid syndrome with venous thromboembolism: Impact of the European Medicines Agency guidance |
| title_full | Direct oral anticoagulants in antiphospholipid syndrome with venous thromboembolism: Impact of the European Medicines Agency guidance |
| title_fullStr | Direct oral anticoagulants in antiphospholipid syndrome with venous thromboembolism: Impact of the European Medicines Agency guidance |
| title_full_unstemmed | Direct oral anticoagulants in antiphospholipid syndrome with venous thromboembolism: Impact of the European Medicines Agency guidance |
| title_short | Direct oral anticoagulants in antiphospholipid syndrome with venous thromboembolism: Impact of the European Medicines Agency guidance |
| title_sort | direct oral anticoagulants in antiphospholipid syndrome with venous thromboembolism: impact of the european medicines agency guidance |
| topic | Commentaries |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6971326/ https://www.ncbi.nlm.nih.gov/pubmed/31989078 http://dx.doi.org/10.1002/rth2.12287 |
| work_keys_str_mv | AT fazilimasarret directoralanticoagulantsinantiphospholipidsyndromewithvenousthromboembolismimpactoftheeuropeanmedicinesagencyguidance AT stevensscottm directoralanticoagulantsinantiphospholipidsyndromewithvenousthromboembolismimpactoftheeuropeanmedicinesagencyguidance AT wollerscottc directoralanticoagulantsinantiphospholipidsyndromewithvenousthromboembolismimpactoftheeuropeanmedicinesagencyguidance |